Kuros Biosciences AG
Research Kuros Biosciences AG (KURN) on Bullrun: market cap CHF 755.26M, P/E 319.2. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerKURN
- ExchangeSW
- CountrySwitzerland
- SectorHealthcare
- IndustryMedical Devices
- CurrencyCHF
- Market capCHF 755.26M
- P/E319.2
- Financial periodFY2025
- RevenueCHF 146.06M
- Revenue growth71.5%
- Net incomeCHF 2.55M
- Free cash flow-CHF 2.89M
- Gross margin88.6%
Valuation Snapshot
latest market cap is CHF 755.26M; P/E is 319.2.
About Kuros Biosciences AG
Kuros Biosciences AG engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally. It operates through two segments, Medical Devices and Legacy Portfolio. The company provides MagnetOs Granules, an advanced bone graft based on the submicron needle-shaped NeedleGrip surface technology; MagnetOs Putty, a mold uses to fill bony voids for intervertebral disc space or posterolateral spine;
Frequently asked questions
What is Kuros Biosciences AG's market cap?
Kuros Biosciences AG's market capitalization is CHF 755.26M.
What is Kuros Biosciences AG's P/E ratio?
Kuros Biosciences AG's price-to-earnings (P/E) ratio is 319.2.
What does Kuros Biosciences AG do?
Kuros Biosciences AG engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally. It operates through two segments, Medical Devices and Legacy Portfolio.